Performance of Population Pharmacokinetic Models in Predicting Polymyxin B Exposures

Polymyxin B is the last line of defense in treating multidrug-resistant gram-negative bacterial infections. Dosing of polymyxin B is currently based on total body weight, and a substantial intersubject variability has been reported. We evaluated the performance of different population pharmacokineti...

Descripción completa

Detalles Bibliográficos
Autores principales: Tam, Vincent H., Lee, Lawrence S., Ng, Tat-Ming, Lim, Tze-Peng, Cherng, Benjamin P. Z., Adewusi, Hafeez, Hee, Kim H., Ding, Ying, Chung, Shimin Jasmine, Ling, Li-Min, Chlebicki, Piotr, Kwa, Andrea L. H., Lye, David C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698783/
https://www.ncbi.nlm.nih.gov/pubmed/33217914
http://dx.doi.org/10.3390/microorganisms8111814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698783/
https://www.ncbi.nlm.nih.gov/pubmed/33217914
http://dx.doi.org/10.3390/microorganisms8111814

Ejemplares similares